Q3 FY2026 · ended Sep 30, 2026 · Revenue $232.87M, +187.1% YoY · Filed Nov 5, 2026
Core Scientific, Inc./tx (CORZ) files with the SEC under industry code 6199, Finance Services. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $232.9 million and net income of $1.2 billion. Free cash flow was -$475.4 million. As of Sep 30, 2026 it held $803.9 million in cash and investments and $4.4 billion in total debt.
Revenue
$232.87M
+187.1% vs year-ago quarter
Net income
$1.18B
+918.0% vs year-ago quarter
Operating cash flow
$65.29M
-50.5% vs year-ago quarter
Free cash flow
$-475.44M
-321.8% vs year-ago quarter
EPS
$0.47
+204.4% vs year-ago quarter
Dividend per share
None
Shares outstanding
322.24M
+3.9% vs year-ago quarter
Net cash
$-3.60B
Q3 FY2026
Operating margin
-73.3%
TTM
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- CORZ (Nasdaq), CORZR (OTC), CORZW (Nasdaq), CORZZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Dover, DE
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1839341
- Former names
- Power & Digital Infrastructure Acquisition Corp. (until Jan 19, 2022)
Other Finance Services companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $232.9M | $164.2M | $115.2M | $79.8M | $81.1M |
| Operating income | $72.3M | -$78.5M | -$310.4M | -$117.5M | -$54.8M |
| Net income | $1.2B | -$1.2B | -$347.2M | $216.0M | -$144.0M |
| Diluted EPS | $0.47 | -$3.32 | -$1.06 | $0.60 | -$0.45 |
| Operating cash flow | $65.3M | -$18.9M | $249.9M | $157.5M | $131.8M |
| Free cash flow | -$475.4M | -$583.9M | -$139.3M | -$121.7M | -$112.7M |
| Total assets | $5.9B | $5.3B | $3.1B | $2.3B | $2.2B |
| Total liabilities | $7.0B | $7.7B | $4.4B | $3.3B | $3.4B |
| Stockholders' equity | -$1.1B | -$2.4B | -$1.3B | -$962.7M | -$1.3B |
| Cash and investments | $803.9M | $1.8B | $1.0B | $311.4M | $453.4M |
| Total debt | $4.4B | $4.4B | $2.2B | $102.2M | $102.2M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Aug 27, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 14, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
All 681 Core Scientific, Inc./tx SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.